Achieve Life Sciences

Yahoo Finance • 4 months ago

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

SEATTLE and VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline... Full story

Yahoo Finance • 5 months ago

FDA Accepts Achieve Life Sciences, Inc. (ACHV) NDA Application for Cytisinicline in Smoking Cessation

Achieve Life Sciences Inc. (NASDAQ:ACHV) is one of the Canadian penny stocks to buy right now. Lake Street’s Thomas Flaten maintained a Buy rating on Achieve Life Sciences Inc. (NASDAQ:ACHV) at $11.00 on November 7.FDA Accepts Achieve Life... Full story

Yahoo Finance • 5 months ago

Achieve Life Sciences outlines expedited FDA review for cytisinicline and targets Q3/Q4 2026 launch

Earnings Call Insights: Achieve Life Sciences (ACHV) Q3 2025 MANAGEMENT VIEW * CEO Richard A. Stewart described the quarter as "another truly significant quarter for Achieve in our mission to get a new treatment for nicotine dependence... Full story

Yahoo Finance • 5 months ago

Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program

One of Only Nine Therapies Chosen for the Inaugural FDA Commissioner’s National Priority Voucher for E-cigarette or Vaping Cessation Conference Call Scheduled for 8:30 AM EST Today, November 6, 2025 SEATTLE and VANCOUVER, British Colum... Full story

Yahoo Finance • 5 months ago

Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation

120-Day Safety Update Submitted to FDA ORCA-OL Long-Term Safety Trial Successfully Concluded DSMC Completes Final Review of Cytisinicline, Finds No Drug Safety Concerns SEATTLE and VANCOUVER, British Columbia, Nov. 03, 2025 (GLOBE NEW... Full story

Yahoo Finance • 5 months ago

Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025

SEATTLE and VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline... Full story

Yahoo Finance • 6 months ago

Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer

SEATTLE and VANCOUVER, British Columbia, Oct. 20, 2025 (GLOBE NEWSWIRE) --  Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisiniclin... Full story

Yahoo Finance • 6 months ago

Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation

Potential First-in-Class Treatment for Nicotine E-cigarette or Vaping Cessation Receives Unprecedented Expedited Review Pathway One of Only Nine Therapies Chosen for the FDA’s Inaugural National Priority Voucher Program SEATTLE and VANCO... Full story

Yahoo Finance • 6 months ago

Achieve, Disc, Revolution among winners of initial FDA national priority vouchers

[US Food and Drug Administration (FDA)] Achieve Life Sciences (NASDAQ:ACHV [https://seekingalpha.com/symbol/ACHV]), Disc Medicine (NASDAQ:IRON [https://seekingalpha.com/symbol/IRON]), and Revolution Medicines (NASDAQ:RVMD [https://seeking... Full story

Yahoo Finance • 6 months ago

Achieve Life Sciences Announces Granting of New Hire Inducement Awards

SEATTLE and VANCOUVER, British Columbia, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline... Full story

Yahoo Finance • 7 months ago

Achieve Life Sciences Announces Publication in Thorax of Data Demonstrating Cytisinicline’s Potential Efficacy and Tolerability for Smoking Cessation in Individuals with COPD

SEATTLE and VANCOUVER, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisiniclin... Full story

Yahoo Finance • 7 months ago

Achieve Life Sciences Promotes Craig Donnelly to Chief Operations Officer

SEATTLE and VANCOUVER, British Columbia, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisiniclin... Full story

Yahoo Finance • 7 months ago

Achieve Life Sciences gets new interim chief medical officer

* Achieve Life Sciences (NASDAQ:ACHV [https://seekingalpha.com/symbol/ACHV]) said that [https://seekingalpha.com/pr/20230175-achieve-life-sciences-names-dr-mark-rubinstein-interim-chief-medical-officer] Mark Rubinstein, M.D., will assume... Full story

Yahoo Finance • 7 months ago

Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer

SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisiniclin... Full story

Yahoo Finance • 7 months ago

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

SEATTLE and VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisiniclin... Full story

Yahoo Finance • 8 months ago

Which stocks are moving before the opening bell on Monday?

As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT O... Full story

Yahoo Finance • 8 months ago

Achieve Life Sciences Inc (NASDAQ:ACHV) Reports Q2 2025 Results: Revenue in Line, Narrow EPS Beat Drives Pre-Market Gains

Achieve Life Sciences Inc (NASDAQ:ACHV [https://www.chartmill.com/stock/quote/ACHV/profile]) reported its second-quarter 2025 financial results, posting revenue of $0.0 and an earnings per share (EPS) loss of $0.37. These figures were larg... Full story

Yahoo Finance • 9 months ago

Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference

SEATTLE and VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline... Full story

Yahoo Finance • 9 months ago

Should You Hold Achieve Life Sciences (ACHV)?

Rogue Funds, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund depreciated 12.4% net of fees in the quarter. The firm anticipates significant volatility... Full story

Yahoo Finance • 9 months ago

Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters’ Option to Purchase Additional Securities

SEATTLE and VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline... Full story